SPONSOR
Beijing Shijitan Hospital, Capital Medical University
Total Trials
2
Recruiting
2
Phases
N/A
Beijing Shijitan Hospital, Capital Medical University is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Acute Ischemic Stroke, Hypothermia, Cerebral Autoregulation.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beijing Shijitan Hospital, Capital Medical University
How many clinical trials has Beijing Shijitan Hospital, Capital Medical University sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Beijing Shijitan Hospital, Capital Medical University, of which 2 are actively recruiting participants. These trials cover conditions including Acute Ischemic Stroke, Hypothermia, Cerebral Autoregulation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beijing Shijitan Hospital, Capital Medical University research focus on?
Beijing Shijitan Hospital, Capital Medical University clinical trials span Acute Ischemic Stroke, Hypothermia, Cerebral Autoregulation. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Beijing Shijitan Hospital, Capital Medical University clinical trial?
To participate in a Beijing Shijitan Hospital, Capital Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beijing Shijitan Hospital, Capital Medical University trials with current recruitment status updated daily.
Clinical Trials by Beijing Shijitan Hospital, Capital Medical University
NCT06485427
Recruiting
Safety and Efficacy of Selective Intra-Arterial Cooling Infusion Combined With EVT in Acute Ischemic Stroke
Acute Ischemic Stroke
NCT07556068
Recruiting
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation
Acute Ischemic Stroke
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology